secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001641489-24-000014
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics elects Anne Phillips as director; Fry and Weiner resign
------------------------------------------------------------------------

- Anne Phillips elected director effective March 13, 2024; will chair Compensation Committee and serve on Audit Committee.
- John Fry and Howard Weiner resigned as directors effective upon filing of the 2023 Annual Report on March 13, 2024.
- Ms. Phillips is independent under Nasdaq rules and will enter standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000014/0001641489-24-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000014/vtvt-20240313.htm
  HTML page:      https://secwatch.observer/filing/0001641489-24-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer